Experimental heart drug reduces Lp(a) levels, but fails to impact outcomes—what went wrong?

Coverage, in order

1. 1d ago
   
   Cardiovascular Business indie

   Experimental heart drug reduces Lp(a) levels, but fails to impact outcomes—what went wrong?

   The big question on everyone's mind: Why was this trial neutral when the drug was so effective at reducing Lp(a) levels?

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.